Ki Summary

Reaction Details

Report a problem with these data

Target

GTPase KRas [G12C]

Ligand

BDBM609015

Substrate/Competitor

n/a

Meas. Tech.

Scintillation Proximity Assay (SPA)

IC50

12.0±n/a nM

Citation

Cotesta, S; Gerspacher, M; Leblanc, C; Lorthiois, EL; Liu, B; Machauer, R; Mah, R; Mura, C; Rigollier, P; Schneider, N; Stutz, S; Vaupel, A; Warin, N; Wilcken, R Pyrazolyl derivatives useful as anti-cancer agents US Patent US11702409 Publication Date 7/18/2023

More Info.:

Get all data from this article, Assay Method

GTPase KRas [G12C]

Name:

GTPase KRas [G12C]

Synonyms:

GTPase KRas (G12C) | KRAS | KRAS2 | RASK2 | RASK_HUMAN

Type:

Enzyme Catalytic Domain

Mol. Mass.:

21702.19

Organism:

Homo sapiens (Human)

Description:

P01116[G12C]

Residue:

189

Sequence:

MTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDL
PSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGC
VKIKKCIIM

BDBM609015

n/a

Name

BDBM609015

Synonyms:

US11702409, Example 82a | US11702409, Example 82b

Type

Small organic molecule

Emp. Form.

C34H37ClN8O2

Mol. Mass.

625.163

SMILES

COC1CN(CCn2cc3cc(ccc3n2)-c2nn(C3CC4(C3)CN(C4)C(=O)C=C)c(C)c2-c2c(Cl)c(C)cc3[nH]ncc23)C1 |(11.96,-2.41,;10.87,-1.32,;9.39,-1.72,;8.62,-3.05,;7.28,-2.28,;5.79,-2.68,;4.71,-1.59,;3.22,-1.99,;2.07,-.96,;.74,-1.73,;-.72,-1.26,;-1.87,-2.29,;-1.55,-3.79,;-.08,-4.27,;1.06,-3.24,;2.59,-3.4,;-3.33,-1.81,;-3.81,-.35,;-5.35,-.35,;-6.12,.99,;-7.61,1.39,;-7.21,2.87,;-5.72,2.48,;-8.7,3.27,;-8.3,4.76,;-6.81,4.36,;-9.39,5.85,;-8.99,7.34,;-10.87,5.45,;-11.96,6.54,;-5.83,-1.81,;-7.29,-2.29,;-4.58,-2.72,;-4.58,-4.26,;-3.25,-5.03,;-1.76,-4.63,;-3.25,-6.57,;-1.91,-7.34,;-4.58,-7.34,;-5.91,-6.57,;-7.38,-7.04,;-8.28,-5.8,;-7.38,-4.55,;-5.91,-5.03,;8.05,-.95,)|

Structure